TheraVasc's Series A Round

TheraVasc raised a round of funding on September 23, 2010.

TheraVasc is a privately-held biotechnology company with offices in Louisiana, focused on the development of vascular therapies with decreased risks through the repositioning of drugs with known safet…

Articles about TheraVasc's Series A Round: